Literature DB >> 11397093

Molecular basis for immune complex recognition: a comparison of Fc-receptor structures.

P Sondermann1, J Kaiser, U Jacob.   

Abstract

Once antigen is opsonised by IgG it is removed from the circulation by Fcgamma-receptor expressing cells. Fcgamma-receptors are type I transmembrane molecules that carry extracellular parts consisting of two or three immunoglobulin domains. Previously solved structures of Fc-receptors reveal that the N-terminal two Ig-like domains are arranged in a steep angle forming a heart-shaped structure. The crystal structure of the FcgammaRIII/hIgG1-Fc-fragment demonstrated that the Fc-fragment is recognised through loops of the C-terminal receptor domain of the FcgammaRIII. As the overall structure of the FcRs and their Ig ligands are very similar we modelled the Ig complexes with FcgammaRI, FcgammaRII and FcepsilonRIalpha based on the FcgammaRIII/hIgG1-Fc-fragment structure. The obtained models are consistent with the observed biochemical data and may explain the observed specificity and affinities. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11397093     DOI: 10.1006/jmbi.2001.4670

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  40 in total

1.  An unusual Fc receptor-related protein expressed in human centroblasts.

Authors:  Fabio Facchetti; Marina Cella; Silvana Festa; Daved H Fremont; Marco Colonna
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

Review 2.  Engineered CD3 antibodies for immunosuppression.

Authors:  L Renders; T Valerius
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

3.  Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcγ receptor binding and antibody-dependent cell-mediated cytotoxicity activities.

Authors:  Shan Chung; Valerie Quarmby; Xiaoying Gao; Yong Ying; Linda Lin; Chae Reed; Chris Fong; Wendy Lau; Zhihua J Qiu; Amy Shen; Martin Vanderlaan; An Song
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

4.  Crystal structure of Fcγ receptor I and its implication in high affinity γ-immunoglobulin binding.

Authors:  Jinghua Lu; Jeff L Ellsworth; Nels Hamacher; Si Won Oak; Peter D Sun
Journal:  J Biol Chem       Date:  2011-09-29       Impact factor: 5.157

Review 5.  The Role and Function of Fcγ Receptors on Myeloid Cells.

Authors:  Stylianos Bournazos; Taia T Wang; Jeffrey V Ravetch
Journal:  Microbiol Spectr       Date:  2016-12

6.  Engineered antibody Fc variants with enhanced effector function.

Authors:  Greg A Lazar; Wei Dang; Sher Karki; Omid Vafa; Judy S Peng; Linus Hyun; Cheryl Chan; Helen S Chung; Araz Eivazi; Sean C Yoder; Jost Vielmetter; David F Carmichael; Robert J Hayes; Bassil I Dahiyat
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

7.  The chicken leukocyte receptor complex encodes a primordial, activating, high-affinity IgY Fc receptor.

Authors:  Birgit C Viertlboeck; Sonja Schweinsberg; Matthias A Hanczaruk; Ramona Schmitt; Louis Du Pasquier; Friedrich W Herberg; Thomas W Göbel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-02       Impact factor: 11.205

8.  Structure of a Therapeutic Full-Length Anti-NPRA IgG4 Antibody: Dissecting Conformational Diversity.

Authors:  Michaela Blech; Stefan Hörer; Alexander B Kuhn; Sebastian Kube; Hendrik Göddeke; Hans Kiefer; Yuguo Zang; Yannic Alber; Stefan M Kast; Martin Westermann; Mark D Tully; Lars V Schäfer; Patrick Garidel
Journal:  Biophys J       Date:  2019-04-05       Impact factor: 4.033

Review 9.  Diversification of IgG effector functions.

Authors:  Stylianos Bournazos; Jeffrey V Ravetch
Journal:  Int Immunol       Date:  2017-07-01       Impact factor: 4.823

10.  The quality of chimpanzee T-cell activation and simian immunodeficiency virus/human immunodeficiency virus susceptibility achieved via antibody-mediated T-cell receptor/CD3 stimulation is a function of the anti-CD3 antibody isotype.

Authors:  Frederic Bibollet-Ruche; Brett A McKinney; Alexandra Duverger; Frederic H Wagner; Aftab A Ansari; Olaf Kutsch
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.